News
Stockhead on MSN18m
Health Check: Cancer drug developers drive further positive Car-T resultsTwo of the leading developers of Car-T immuno-oncology drugs, Imugene and Chimeric have unveiled further positive trial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback